What do the numbers say about Synopsys (SNPS)? Here's a look at its financials, capital returns, and valuation.
Top-Line Growth
Year-over-year, Synopsys grew revenue by 15.1% — from $6.13B in FY2024 to $7.05B in FY2025.
Synopsys has compounded revenue at 12.1% over 10 years — good, consistent top-line expansion from $2.24B to $7.05B.
In terms of scale, Synopsys's $7.05B in annual revenue positions it as a mid-cap information technology company.
With 10 straight years of revenue growth, this isn't a blip — the trajectory is clear for Synopsys.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | $7.05B | +15.1% |
| FY2024 | $6.13B | +15.2% |
| FY2023 | $5.32B | +15.2% |
| FY2022 | $4.62B | +9.8% |
| FY2021 | $4.20B | +14.1% |
Dive deeper into Synopsys's top-line performance
Business Segments
Looking under the hood at Synopsys's revenue mix for FY2025.
Synopsys Business Segment Performance (FY2025)
| Segment | Revenue | % of Total |
|---|---|---|
| License and Maintenance | $3.49B | 49.5% |
| License | $2.01B | 28.5% |
| Technology Service | $1.55B | 22.0% |
At 49.5% of total revenue, License and Maintenance is by far Synopsys's largest segment.
The License segment is gaining share, growing 11.6% and now accounting for 28.5% of revenue.
Notably, Technology Service grew 41.2% YoY, taking its share to 22.0% of total revenue.
Geographically, Synopsys's revenue is split across United States (44%), Other Countries (18%), South Korea (13%), Europe (13%), and China (12%).
Synopsys Earnings & Margins
A 41.1% decline brought Synopsys's net income down to $1.33B in FY2025 from $2.26B.
Net profit margin compressed to 18.9% in FY2025 from 36.9% in FY2024.
On a per-share basis, diluted earnings were $8.04 in FY2025 versus $14.51 in FY2024.
Explore the profitability trend in detail below
Synopsys Shareholder Returns
At present, Synopsys does not distribute a dividend to shareholders.
On the buyback front, Synopsys has spent $5.03B repurchasing shares over 9 years, reducing the float and boosting per-share metrics.
Explore Synopsys's capital return activity in the charts below
Balance Sheet Overview
| Metric | Value |
|---|---|
| Cash & Short-term Investments | $2.96B |
| Total Debt | $13.48B |
| Shareholders' Equity | $28.33B |
| Total Assets | $48.22B |
| Debt-to-Equity Ratio | 0.48x |
| Current Ratio | 1.62x |
| Interest Coverage | 2.0x |
| Free Cash Flow (TTM) | $1.35B |
Synopsys has a debt-to-equity ratio of 0.48, a current ratio of 1.62, interest coverage of 2.0x in FY2025, which suggest adequate financial health with manageable leverage.
Synopsys's balance sheet is in strong shape: $2.96B in cash against $13.48B in total debt, with a debt-to-equity ratio of 0.48x.
The current ratio of 1.62x indicates Synopsys can comfortably meet short-term obligations.
With interest coverage at 2.0x, Synopsys has enough earnings to meet its debt obligations, though not by a wide margin.
Free cash flow of $1.35B underscores Synopsys's ability to self-fund growth and return capital to shareholders.
See the detailed financial health breakdown in the charts
Synopsys employed 28,000 people as of FY2025, about $251.9K in revenue per employee.
See Synopsys's full employee count history and revenue per employee
Synopsys Valuation Analysis
Is Synopsys stock overvalued or undervalued? Here's what our valuation models suggest.
Synopsys shares are currently trading at $392.07.
The P/E Ratio model estimates an intrinsic value of $480, implying a 18.4% upside from the current price.
We also calculate intrinsic value using the DCF and EPS Growth models. Sign up to see the full breakdown with fair value estimates.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | $480 | 18.4% upside to fair value |
| DCF | Upgrade | Upgrade |
| EPS Growth | Upgrade | Upgrade |
Key Highlights
To sum up Synopsys's financial position: the data paints a clear picture for investors evaluating this information technology stock.
Revenue of $7.05B in FY2025, up 15.1% year-over-year.
Long-term revenue has been compounding at 12.1% annually over 10 years.
The company is profitable, with a net margin of 18.9% and net income of $1.33B.
Conservative balance sheet with a D/E ratio of 0.48x.
The P/E Ratio model implies 18.4% upside to fair value. The remaining 2 models are worth cross-checking before drawing a conclusion. Sign up to see the full analysis.
Scroll down for interactive charts covering Synopsys's full financial history and valuation models.